Literature DB >> 22537654

Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery.

K Annette Mizuguchi1, Aya Mitani, Sushrut S Waikar, Peter Ireland, Christia Panizales, Gretchen Deluke, David J Sugarbaker, Joseph V Bonventre, Gyorgy Frendl.   

Abstract

BACKGROUND AND OBJECTIVES: AKI leads to increased morbidity and mortality and progression to chronic kidney injury is a frequent consequence of AKI. Surgical treatment of mesothelioma is associated with increased risk for kidney injury. However, sustained kidney injury may limit therapeutic options for treating residual cancer. This study hypothesized that patients with significant serum creatinine (sCr) elevation within 48 hours of surgery would be at risk for sustained kidney injury. The goal was to determine the best acute sCr measure predictive of sustained kidney injury defined as a 50% increase in sCr from baseline measured 2-4 weeks after surgery. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a prospective, observational cohort of surgical patients with mesothelioma, receiver operator characteristic curves were generated for the 24- and 48-hour absolute difference and relative sCr change over baseline in the derivation cohort (n=279). The prediction was tested in a validation cohort (n=207). The ability of various other AKI definitions to predict sustained kidney injury was evaluated.
RESULTS: Sustained kidney injury occurred in 9.8% of patients in the derivation cohort. A ≥59% increase in sCr 48 hours after surgery was most predictive of sustained kidney injury (c statistic=0.78). Among other AKI definitions, a sCr increase of 0.3 mg/dl in 24 hours or 0.5 mg/dl increase in 48 hours (Waikar and Bonventre criteria) also reliably predicted sustained kidney injury.
CONCLUSIONS: Development of clinically significant sustained kidney injury can be predicted by acute postoperative sCr elevation in patients treated for mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537654      PMCID: PMC3386676          DOI: 10.2215/CJN.12401211

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  23 in total

1.  A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.

Authors:  Julia Lewis; Tom Greene; Lawrence Appel; Gabriel Contreras; Janice Douglas; Jim Lash; Robert Toto; Fredrick Van Lente; Xuelei Wang; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

Review 2.  Diagnosis and treatment of acute tubular necrosis.

Authors:  Matthew L Esson; Robert W Schrier
Journal:  Ann Intern Med       Date:  2002-11-05       Impact factor: 25.391

3.  Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.

Authors:  V W Rusch; D Niedzwiecki; Y Tao; C Menendez-Botet; A Dnistrian; D Kelsen; L Saltz; M Markman
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544

Review 4.  Acute renal failure.

Authors:  H R Brady; G G Singer
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

Review 5.  Acute renal failure.

Authors:  R Thadhani; M Pascual; J V Bonventre
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

6.  Candidate reference methods for determining target values for cholesterol, creatinine, uric acid, and glucose in external quality assessment and internal accuracy control. I. Method setup.

Authors:  D Stöckl; H Reinauer
Journal:  Clin Chem       Date:  1993-06       Impact factor: 8.327

Review 7.  Kidney dysfunction in the postoperative period.

Authors:  J W Sear
Journal:  Br J Anaesth       Date:  2004-11-05       Impact factor: 9.166

Review 8.  Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications.

Authors:  Michael Y Chang; David J Sugarbaker
Journal:  Thorac Surg Clin       Date:  2004-11       Impact factor: 1.750

9.  Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.

Authors:  David J Sugarbaker; Michael T Jaklitsch; Raphael Bueno; William Richards; Jeanne Lukanich; Steven J Mentzer; Yolonda Colson; Phillip Linden; Michael Chang; Leah Capalbo; Elizabeth Oldread; Siyamek Neragi-Miandoab; Scott J Swanson; Lambros S Zellos
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

Review 10.  Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Authors:  Rinaldo Bellomo; Claudio Ronco; John A Kellum; Ravindra L Mehta; Paul Palevsky
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097

View more
  3 in total

1.  Simple Postoperative AKI Risk (SPARK) Classification before Noncardiac Surgery: A Prediction Index Development Study with External Validation.

Authors:  Sehoon Park; Hyunjeong Cho; Seokwoo Park; Soojin Lee; Kwangsoo Kim; Hyung Jin Yoon; Jiwon Park; Yunhee Choi; Suehyun Lee; Ju Han Kim; Sejoong Kim; Ho Jun Chin; Dong Ki Kim; Kwon Wook Joo; Yon Su Kim; Hajeong Lee
Journal:  J Am Soc Nephrol       Date:  2018-12-18       Impact factor: 10.121

2.  Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.

Authors:  H Liang; H-Z Liu; H-B Wang; J-Y Zhong; C-X Yang; B Zhang
Journal:  Inflamm Res       Date:  2017-02-21       Impact factor: 4.575

3.  Awareness, incidence and clinical significance of acute kidney injury after non-general anesthesia: A retrospective cohort study.

Authors:  Sehoon Park; Soojin Lee; Anna Lee; Jin Hyuk Paek; Ho Jun Chin; Ki Young Na; Dong-Wan Chae; Sejoong Kim
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.